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A necessary step in the differentiation of stem cells into functionally competent
T cells involves selection of precursor cells based on their receptor specificity for
thymic MHC-encoded determinants (1). In support ofthis concept is the observa-
tion that MHC class II-restricted CD4' T cells fail to appear in mice whose Ia de-
terminants are blocked by anti-la mAbs administered in vivo from birth onward
(2). However, CD4+ T cells are not the only cells reactive to MHC class II deter-
minants, as there exists a CD8+ T cell subset that is also reactive to MHC class
II determinants (3, 4). This CD8 + class II-reactive CTL subset represents the pri-
mary exception to the correlation ofCD4 expression with MHC class II recognition
and CD8 expression with MHC class I recognition (5). The present study was un-
dertaken to determine if the differentiation of CD8+ class II-reactive T cells, like
that of CD4+ T cells, required engagement of MHC class II determinants during
development. We addressed this issue in mice chronically administered anti-Ia mAb
where the differentiation of CD4* class II-specific T cells was arrested. We found
that, in contrast to its arrest of CD4' T cell differentiation, in vivo anti-la blockade
did not demonstrably interfere with the differentiation of Ia-reactive CD8+ T cells.
Materials and Methods
Animals.
￿
C57BL/6 (116) and C57BL/10 (1110) mice were purchased from TheJackson Lab-
oratory Bar Harbor, ME. B6.C-H-26'"' (bml) and B6.C-H-2'12 (bml2) mice were bred in
our own animal colony.
Monoclonal Antibodies.
￿
Anti-I-Ab mAb was purified Ig from ascites of either the Y-31? or
M5/114 hybridoma cell lines obtained from the American Type Culture Collection, Rock-
ville, MD. Anti-CD4 mAb was a culture supernatant ofthe anti-L3T4 hybrrdomms cell line
GK1.5 (6). Anti-CD8 mAb was a culture supernatant ofthe anti-Lyt-2.2 hybridoma cell line
83-12-5 produced by Dr. J. Bluestone, NIH.
In VivoAnti-la Treatment.
￿
Neonatal B6 mice were treated within 24 h ofbirth with purified
anti-I-Ab mAb prepared from ascites from either hybridoma Y-3P or M5/114. Intraperitoneal
injections of 200 ug, 400 wg, and 600 jig of antibody were given daily during the first, second,
and third week oflife, respectively. Saline-injected littermates were used as control animals.
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In Vitro Generation of CTL.
￿
CTL were generated in 2-ml cultures consisting of 4 x 106
responderspleen cells and 4 x 106 2,000 rad irradiated stimulator spleen cells in RPMIcul-
ture mediumsupplemented withthe 18-h supernatant fromCon A-induced spleen cellcul-
turestowhich a-methyl-mannoside hadbeen added(ConASN)(4). On day5, graded numbers
ofeffector cells were added to 4 x 103 "Cr-labeled LPS-induced spleen target cells.
Flow Cytometry.
￿
Two- and three-color immunofluorescence analysis of spleen cells and
thymocytes from saline-treated control and anti-I-AbmAb-treatedmice wasperformedusing
amodifiedBecton Dickinson&Co. (MountainView, CA)Dual LaserFACSII asdescribed(2).
Results and Discussion
B6 mice were administered anti-I-A' mAb by daily injections beginning at birth
and continuing for up to 4 wk. Treated animals were assessed at 2-4 wk of age,
with saline-injected littermates serving as control animals. The effect of anti-I-Ab
mAb administration on the appearance ofmature CD4+ and CD8' T cell's in the
thymus andspleens ofthe five experimental animal groups used inthe present study
was assessed by two-color immunofluorescence and flow cytometry (Table I). Con-
sistent with previous reports (2), both the thymus and spleen of anti-I-Ab-treated
B6 mice were profoundly depleted of single-positive CD4+CD8- T cells, but con-
tained single-positive CD8+CD4- T cells in nearly normal numbers (Table I). The
experimental animals used in the present study were also depleted ofmature CD4'
T cells by functional criteria, as indicated by their ability to secrete IL-2 only in
response to stimulator cells expressing MHC class I (Kbm1) but not MHC class II
(I-Abrn12) alloantigens (data not shown). Thus, by both physical and functional as-
sessments, the anti-I-Ab treated H-2b mice used in the present study were depleted
of mature CD4' T cells.
To assess the effect ofanti-Ia treatment on the differentiation ofCD8' Ia-reactive
CTL, unprimed cell populations from control and anti-I-Ab-treated mice were
stimulated in vitro with MHC class II (I-A112) disparate stimulators, and the cul-
turesassayed on day 5 for the generation ofclass II-allospecific CTL bytheir ability
to lyse LPS-induced blast target cells (Fig. 1). Anti-I-Ab-treated mice did contain
class II-allospecific CTL precursors (pCTL) as demonstrated by their ability to
generate anti-I-Abm12 class II allospecific CTL (Fig. 1, a and b) whose lysis ofbm12
target cells was blocked by anti-la mAb added to the cytolytic effect assay (Fig. 1,
c and e). Furthermore, the generation of class II-allospecific CTL from anti-I-
Ab-treated mice was blocked by the addition of anti-la mAb to the response cul-
tures (Fig. 1, c and e). The antibody blockade in each case was specific because the
TABLE I
Phenotype of T Cells Present in H-2b Mice Injected with Anti-I-Ab mAb
In vivo
￿
CD4'CD8- T cells
￿
CD8' CD4- T cells
treatment Thymus Spleen Thymus Spleen
%
￿
%
Saline
￿
11 .1 t 1.4
￿
9.9 t 3.4
￿
2.7 t 0.7
￿
6.3 t 1.8
al-Ab
￿
0.8 t 0.1
￿
0.5 t 0.1
￿
2.5 f 0.6
￿
4.7 t 1.4
Two-color flow Cyometry analysis of cell surface CD4and CD8 expression in
thymocytes and spleen cells from five independent groups of anti-I-Ab-treated
and control mice. Data are expressed as mean t SE.40
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Exp. 2
￿
Exp. 3
￿
Exp. 4
￿
FtcuRE 1.
￿
Generation ofCD8'
class II allospecific CTL in B6
mice treated with anti-I-Ab
mAb. Experimental groups are
displayed in top panels, control
groups are displayed in bottom
panels. Exp. 1: Spleen cells from
B6 mice chronically injected
with either anti-I-Ab.
(a) or sa-
line (b) and cultured in the pres-
ence of ConASN for 5 d with
bm12 stimulator spleen cells
were tested on LPS-induced
target cells from bm12 (+) or
B6 ("). Exp. 2: Experimental
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thymocytes (c) or experimental
Effector to Target Ratio
￿
splenocytes
￿
(e)
￿
from
￿
anti-I-
Ab-treated B6 animals were cul-
tured in the presence ofConASN for 5 d with bm12 stimulator cells and assayed on LPS-induced bm12
(*) target cells. Control thymocytes (d) or control splenocytes (/) from saline-injected B6 animals were
cultured in the presence of ConASN for 5 d with bml stimulators and assayed on LPS-induced bml
(A) target cells. M5/114 mAb which reacts with both I-All and I-Abrni2 determinants was added (25%
vol/vol) either to the induction cultures (open symbols) or to the CTL effector assay (half-filled symbols).
(Closedsymbols) Responses of CTL generated in the absence of anti-I-Ab mAb and assayed in the ab-
sence of anti-I-Ab mAb. Exp. 3 : Spleen cells from anti-I-Ab-treated B6 mice were cultured with bm12
stimulators for 5 d in the presence of ConASN and assayed on bm12 LPS-induced bm12 target cells
(g). The effector cells were treated just before the CTL effector assay with C' (*), anti-CD4 mAb +
C' (0), or anti-CD8 mAb + C' (Q). Exp. 4: Spleen cells from anti-I-Ab-treated B6 mice (h and i)
were cultured with either bm12 (h) or bml (i) stimulators in the presence of ConASN for 5 d and then
assayed on LPS-induced blast target cells from stimulator-type bm12 (*) or bml (") mice. The CTL
effector assay was performed either in the absence (closed symbols) or in the presence ofanti-CD8 blocking
antibody (open symbols).
anti-la mAbhad no effect on class I (anti-Kb")-allospecific responses ofcontrol cell
populationswhen added toeither the inductionculturesorthe cytolyticeffector assays
(Fig. 1, d and f). The class 1I-allospecific CTL effectors generated from anti-I-
Ab-treated mice were CD8+CD4- (Fig. 1 g), but anti-CD8 mAb did not block their
lysis ofbm12 target cells (Fig. 1 h), a result similar to that observed for CD8' class
II-allospecificCTLfrom normal mice (3). In contrast, the anti-CD8 mAb didblock
target cell lysis by anti-Kb-1 CTL generated from the same experimental mice(Fig.
1 a). Thus, these results demonstrate that CD8' class II-reactive precursors do
differentiate in mice chronically treated with anti-Ia mAb even though the same
mice are essentially devoid of mature CD4' T cells.
Since anti-I-A'-treated animals contained CD8' CTL reactive with allogeneic
class II determinants, we next assessed their reactivity to selfclass 11 determinants.
However, responder cells from anti-l-Ab-treated mice only generated anti-I-Abm12
CTL but failed to generate CTL against self I-Ab (Fig. 2), a result that cannot be
trivially explained by carryoverofinjected anti-I-Ab mAb into the response cultures
because carryoverofthe injected M5/114 mAb should also have blocked the genera-
tion of anti-I-Ab,t2 CTL since this mAb binds to both la molecules (see Fig. 1).
It is tempting to attribute the tolerance to self-Ia determinants ofthe experimental
mice tothepresencein vivo ofsmallbut tolerogenic amountsofunblocked la deter-
minants. However, few Ia' cells are present in anti-Ia-treated mice (2), and their
la determinants are either blocked by antibody or modulated off the cell surface
a c
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FIGURE 2 .
￿
Failure to detect anti-I-Ab CTL in anti-
I-Ab-treated B6 mice. Splenocytes (solid lines) from
either four individual 3-wk-old anti-I-Ab (M5/114)-
treatedB6 mice (1-1, 2-2, 3-3, 4-4) or from sa-
line injected littermates (") were cultured in vitro
in the presence ofConASN with 2,000 rad irradi-
ated spleen stimulator cells from B6 (left panel) or
bm12 (right panel) . In a different experiment, thymo-
cytes (dashed lines) from either anti-I-Ab (M5/114)-
treated B6 mice (A) or saline-injected littermates (")
were cultured in vitro in the presence ofConASN
with 2,000 rad irradiated spleen stimulator cells from
B6 (leftpanel) or bm12 (rightpanel). CTL effector cells
were assayed on LPS-induced B6 (leftpanesor bm12
(right panel) target cells at the indicated effector-to-
target ratios .
(W van Ewijk andA.M. Kruisbeek, unpublished observations) . It is conceivable, but
unlikely, that CD8+ T cell tolerance to I-Ab determinants results from an anti-(anti-
I-Ab) idiotype-(antiidiotype) regulatory network mediated by CD8+ T cells and ini-
tiated by in vivo administration of anti-I-AbmAb. Whatever the mechanism, these
data indicate that anti-la blockade does not interferewith inductionofself-la toler-
ance in CD8+ Ia-specific T cells .
Finally, the striking contrast in the effect of anti-I-Ab antibody treatment on the
differentiation of CD4+ and CD8+ Ia-reactive T cells made us question if de-
veloping CD4+CD8- thymocytes might somehow be unique targets for direct elimi-
nation by the injected anti-Ia mAb. Because murine thymocytes do passively ac-
quire la determinants that could potentially serve to bind anti-IamAb to their cell
surfaces (7), weexamined expression ofcell surface Ia determinants by distinct thymo-
cyte subpopulations using three-color flow cytometry (Table II) . Cell surface la ex-
pression was detected on only a minority of CD4+CD8- thymocytes, and was no
greater than that found on C134-C138' thymocytes (Table II) . These results argue
against the possibility that CD4+ T cells are unique targets for direct elimination
by circulating anti-la antibodies . Instead, the selective elimination ofCD4+CD8-
T cell differentiation by anti-I-A' mAb treatment appears to be an indirect conse-
quence of blocking I-Ab determinants that are necessary for the differentiation of
CD4+ T cells but that are not necessary for the differentiation of CD8 + T cells,
even those reactive with la allodeterminants .
The present study demonstrates that differentiation of la-reactive CD8+ T cells
does not require engagement ofMHC class II determinants, indicating that their
differentiation either does not involveMHC engagement at all, or involves engage-
ment ofMHC class I determinants . Themost straightforward interpretation of these
results is that la-reactive CD8+ T cells are conventional CD8+ T cells that are
sele-ted during differentiation by self classIMHC determinants, butwhosereceptors
fortuitously crossreact onMHC class II alloantigens with sufficiently high affinity
to lyse allo-la-bearing target cells in theabsence ofeither CD4 or CD8 affinity con-
tributions . In fact, a fewCD8 + CTL clones have been described recently (8, 9) that
do cross reactively recognize both class I and class IIMHC allodeterminants, and
whose lysis of allo-Ia-bearing targets is independent ofCD4 andCD8 affinity con-
tributions .MIZUOCHI ET AL.
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TABLE II
Cell Surface Expression of la Determinants on B10 Thymocytes
Percent la' cells
Whole
￿
Thymocyte subpopulations
thymocytes CD4- 8- CD4+8+ CD4+8- CD4- 8+
34.0
￿
27.2 34.4 29.4 41 .4
Results ofthree-color flow cytometry in which each cell was simultaneously as-
sessed for CD4, CD8, and Ia expression. Percentage of Ia+ cells reflects num-
ber of cells staining positively with anti-I-Ab mAb minus low level nonspecific
background staining by an irrelevant anti-I-Ad mAb.
Ifcurrent conceptsare correctthat thymic selectionresultsfromlowaffinity inter-
actions between developing T cellprecursors and self-MHC, CD4/CD8 affinity con-
tributions to MHC binding should be unnecessary for thymic differentiation be-
cause receptor binding per se should fulfill the low affinity requirements for thymic
differentiation. Yet, thepresentstudyhas observedthat differentiation ofprecursors
into CD4+ T cells strictly requires engagement of la, whereas differentiation of
precursors into CD8+ T cells appears completely independent ofla, regardless of
the receptor specificities they express. Consequently, we would like to suggest that
the primary role ofCD4 and CD8 molecules in T cell differentiation is not to sup-
plement MHC binding affinity, but rather is to generate signals that are necessary
to promote the differentiation ofTcell precursors into mature T cells. We suggest
that CD4engagement ofMHC class II moleculescrosslinks CD4moleculestogether
(McCarthy, S. A., E. Kaldjian, andA. Singer, submittedforpublication)orto MHC-
specific antigen receptor molecules (10), generating activation signals that are strictly
necessary for the differentiation ofprecursors into mature CD4' T cells. Similarly,
CD8 engagement of MHC class I molecules crosslinks CD8 molecules together
(McCarthy, S. A., et al., submitted for publication) or to MHC-specific antigen
receptor molecules (10), generating activation signals that are strictly necessary for
the differentiation of precursors into mature CD8+ T cells. Thus, CD4+ T cell
differentiation would strictly require la engagement and CD8+ T cell differentia-
tion would strictly require class I engagement, regardless ofthe specificity oftheir
antigen receptors.
In conclusion, the present study demonstrates that unlike CD4' Ia-reactive T
cells, differentiation ofCD8' Ia-reactive T cells does not require Ia engagement.
In our opinion, the present study can best be understood by an MHC-dependent
signaling role for CD4 andCD8 molecules inpromoting T cell differentiation, and
that anti-lablockade selectively arrests the differentiation ofCD4+ T cells, not only
because it interferes with receptor-la interactions, but, more importantly, because
it interferes with CD4-Ia interactions.
Summary
The present study was undertaken to assess the Ia differentiation requirements
ofCD8' class II-allospecific CTL, whose CD8' phenotype is apparently "discor-
dant" with their MHC class II reactivity. To do so, we compared the effect of in
vivo anti-la blockade on the differentiation ofla-reactive CD8' CTL with its effect442
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on the differentiation of CD4' T cells. We found that anti-Ia blockade did not de-
tectably interfere with the differentiation of CD8' Ia-reactive CTL, even though
it arrested the differentiation of CD4+ T cells. Thus, the differentiation of CD4+
T cells is strictly dependent upon la engagement, whereas the differentiation of
CD8+ T cells, even those with reactivity against MHC class II alloantigens, does
not require la engagement. These results support the concept that Ia-reactive CD8+
T cells are conventional CD8+ CTL, probably selected by self-class I MHC mole-
cules during differentiation, whose receptors fortuitously crossreact on MHC class
II alloantigens. Taken together, the present data indicate an intimate relationship
between CD4/CD8 expression with MHC class specificity during T cell differentia-
tion and selection. We suggest that an active triggeringrole for CD4 and CD8 acces-
sory molecules in T cell differentiation is best able to explain these observations.
Receivedfor publication 4January 1988 and in revisedform 14 March 1988.
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